ResearchMoz.us include new market research report "Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment" to its huge collection of research reports.
This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages.
View Full Report With TOC: http://www.researchmoz.us/personalized-medicine-and-companion-diagnostic-market-q2-2013-a-strategic-analysis-of-industry-trends-technologies-participants-and-environment-report.html
The personalized medicine (global) market is presented as follows:
- By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
- By Geography (US, UK, EU)
- By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
- By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)
Who should read this report?
- Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
- Industry professionals and business strategists will discover key information to propel their policies
- Investors will gain inside information to dominant players in the industry and future forecasts
- Scientists will get a business perspective and industry insight into how scientific breakthroughs
Find More Reports Related to Pharmaceuticals: http://www.researchmoz.us/pharmaceutical-market-reports-38.html